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Context: In male patients with congenital adrenal hyperplasia
(CAH), testicular adrenal rest tumors are frequently found that may
interfere with gonadal function.
Objective: Our objective was to determine steroid-producing fea-
tures of testicular adrenal rest tumors.
Design and Setting: The study is descriptive and took place at a
university medical center.
Patients: Eight adult CAH patients with bilateral testicular adrenal
rest tumors were treated with testis-sparing surgery.
Interventions: In all but one patient, spermatic veins were cannu-
lated during surgery and blood samples collected to measure the
adrenal-specific steroid 21-deoxycortisol (21DF) and 17-hydroxypro-
gesterone (17OHP) and androstenedione (A). The same parameters
were measured in simultaneously taken peripheral blood. mRNA
concentrations of adrenal-specific enzymes CYP11B1 and CYP11B2
andACTHand angiotensin II (AII) receptors weremeasured in tumor
tissue.
Main Outcome Measures: Adrenal-specific steroids/enzymes were
assessed.
Results: 21DF, 17OHP, and A levels were measurable in all sper-
matic vein samples. The ratio (mean  SD) between spermatic vein
and simultaneously taken peripheral blood samples was 37.8  56.3
(21DF), 132.0  249 (17OHP), and 57.0  68.2 (A). CYP11B1,
CYP11B2, and ACTH and AII receptor mRNAs were detected in all
tumors with a strong correlation between ACTH receptor mRNA in
tumors and 21DF (r  0.85; P  0.015), 17OHP (r  1; P  0.01) and
A (r  0.89; P  0.007) concentrations in peripheral blood.
Conclusion:Testicular adrenal rest tumors produce adrenal-specific
steroids and express adrenal-specific enzymes and ACTH and AII
receptors, confirming the strong resemblance with adrenal tissue.
Because AII receptors are present in tumor tissue, it can be hypoth-
esized that AII may be an additional factor responsible for testicular
adrenal rest tumor growth. (J Clin Endocrinol Metab 92:
3674–3680, 2007)
IN 1940, WILKINS et al. (1) first reported the presence of atesticular tumor in amale patientwith congenital adrenal
hyperplasia (CAH). Two recent studies found that the prev-
alence of testicular tumors in these patients is remarkably
high (2, 3). The tumors are almost always bilaterally present
and have benign features, but because of their location in the
mediastinum testis, they can lead to obstruction of the
seminiferous tubules leading to gonadal dysfunction and
infertility. The testicular tumors are thought to arise from
aberrant adrenal cells in the testes that are stimulated by
ACTH. Therefore, they are called testicular adrenal rest tu-
mors. However, until now, the etiology and functional fea-
tures of the tumors were not completely known. Microscop-
ically, the tumors show features of steroid-producing tissue,
but the histological differentiation between tumors derived
from Leydig cells and from adrenocortical cells is difficult
(4–6).
The clinical observations that highdoses of glucocorticoids
can reduce tumor size, most probably due to suppression of
ACTH secretion, and that tumor growth may be promoted
in conditions where ACTH concentration is high, such as in
poorly controlled CAH patients or in patients with Nelson’s
syndrome or Addison’s disease, suggests the presence of
ACTH receptors on tumor cells (7–11). However, intensify-
ing of glucocorticoid treatment with suppression of ACTH
secretion is not always successful in reducing tumor size and
even in well-controlled CAH patients, with normal or sup-
pressed plasma ACTH levels, testicular adrenal rest tumors
are found (2, 3, 12). Therefore, most probably other unknown
factors contribute to tumor growth.
In the past, a limited number of in vivo and in vitro studies,
mainly in single patients, were performed to investigate the
etiology and the functional features of testicular adrenal rest
tumors in CAH patients. Clark et al. (13) described the pres-
ence of the adrenal-specific enzyme CYP11B1 (11-hydrox-
ylase) in tumor tissue of a single CAH patient with testicular
adrenal rest tumors. Bercovici et al. (14) demonstrated the
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presence of adrenal-specific steroids in one testicular adrenal
rest tumor. The presence of adrenal-specific 11-hydroxy-
lated steroids such as 21-deoxycorticosterone (21DB) and
21-deoxycortisol (21DF) in blood taken from the gonadal
veins is reported in three single cases (14–16). This indicates
the presence of adrenal-like tissue in the testes of these CAH
patients with 21-hydroxylase deficiency, because these ste-
roids can only be synthesized by adrenal-specific 11-hy-
droxylation, without the need of the deficient 21-hydroxy-
lation step.
In the present study, we measured the concentrations of
the adrenal-specific steroid 21DF and of 17-hydroxyproges-
terone (17OHP) and androstenedione (A) in blood taken
from the spermatic veins during testis-sparing surgery in
seven male CAH patients with bilateral testicular adrenal
rest tumors. Furthermore, we measured the mRNA expres-
sion of the adrenal-specific enzymes CYP11B1 and CYP11B2
as well as of ACTH and angiotensin II (AII) receptors in 16
testicular tumors of eight patients by quantitative PCR. We
demonstrate that the testicular tumors in CAHpatients show
functional features of adrenocortical tissue, which is in line
with the hypothesis that they are derived from aberrant
adrenal cells.
Patients and Methods
Patients
Eight male CAH patients (mean age 31 yr; range 23–51 yr) with
bilateral testicular adrenal rest tumors were selected for testis-sparing
surgery because of infertility (n  5), poor hormonal control despite
rigorous treatment (n 2), pain or discomfort (n 2), or hypogonadism
(n 2). Five patients (1, 2, and 4–6) had been treated by intensifying the
glucocorticoid therapy, which was mostly with dexamethasone (DXM),
in the past to reduce tumor size and improve testicular function without
success, suggesting the development of fibrotic or autonomous tissue
within the tumor. Three patients refused intensifying the glucocorticoid
treatment.Written informed consent was obtained from all patients. The
study was approved by the local ethics committee. The patients’ char-
acteristics are listed in Table 1. The diagnosis of CAH due to 21-hy-
droxylase deficiency was confirmed bymutation analysis in all patients.
Sample preparation and the method used for mutation analysis were
performed as described earlier (17). All but one patient had the classic
salt-wasting (SW) form of CAH and were treated with glucocorticoids
and mineralocorticoids since the neonatal period. One patient had the
simple virilizing (SV) form of CAH diagnosed at the age of 5 yr.
In all patients, biochemical and semen analyses were performed
before and after operation to evaluate pituitary-gonadal function. All
patients were azoosperm or oligosperm with low blood inhibin B levels
before operation. In three patients (1, 2, and 5), hypogonadotropic hy-
pogonadism was present due to elevated serum A/estrone levels in
these patients (Table 2). The results of the biochemical analyses have
beendescribed indetail elsewhere (18). For comparison, the samepatient
numbers are used in the current paper.
Spermatic vein sampling
Testicular tumor enucleation took place under general (n  1) or
loco-regional (n  7) anesthesia. Just before operation, all patients re-
ceived 2.5mgDXM iv as stressmedication. In patients 1–4, the operation
started on the left side; in patients 5–8, the operation started on the right
side. Via an inguinal incision and after opening of the inguinal canal, the
spermatic cord was exposed. During this procedure, special care was
taken not to manipulate the testis, to prevent unwanted secretion of
hormones into the circulation. The spermatic vein was cannulated, and
blood samples were collected to measure 21DF, 17OHP, and A concen-
trations. Simultaneously, peripheral blood was collected from a cubital
vein to measure the same hormones. The same procedure was per-
formed at the other side after finishing the operation on the first side.
A second simultaneous peripheral blood sample was not taken. ACTH
stimulation tests or DXM suppression tests were not performed during
spermatic vein cannulation to avoid prolonged anesthesia in the pa-
tients. Patient 1 was operated without spermatic vein sampling. In
patient 7, the spermatic veins at the right side were atrophic, and the
volume of collected blood was not sufficient for biochemical analyses.
All sera were stored at 20 C until measurements.
Tumor tissue preparation
All removed tumor tissue was investigated macroscopically and mi-
croscopically.Aportion of the tumorwas fixed in 10%buffered formalin.
Tissue sections of 5mwere cut and stainedwith hematoxylin and eosin
and with Von Giesons elastin stain. Another portion of the tumor was
frozen immediately in liquid nitrogen and stored at 80 C until
processing.
Hormone assays
Methods of measuring serum LH, FSH, testosterone, inhibin B, and
estrone concentrations were described in detail in an earlier publication
(18). 17OHP and A concentrations in serumwere measured by RIA after
extraction and paper chromatography (19, 20). For 17OHP, the within-
assay coefficient of variation (CV) was 6.1%, and the between-assay CV
8.5% at 4.9 nmol/liter. For A, the intraassay CV was 4.9% and the
interassay CV 7.6% at 4.2 nmol/liter. Serum 21DF was assessed by RIA
after prepurification by means of HPLC of ether extracts of the samples,
including correction for procedural losses. To summarize briefly,
[3H]21DF was added before extraction to correct for procedural losses.
A Hypersil Gold column with a mobile phase consisting of methanol/
water (47/53) gave full separation between 21DF and the potentially
cross-reacting steroids cortisol, corticosterone, and 11-desoxycortisol.
The [3H]21DF-containing fractions were evaporated to dryness and dis-
solved in ethylene glycol-water. The recovered radioactivity was mea-
sured by liquid scintillation counting of an aliquot from the eluate.
Subsequently, [3H]21DF tracer and antiserum (raised against cortisol
21-hemisuccinate-BSA) were added, and after incubation, free and
bound tracer were separated by means of dextran-coated charcoal. The
antibody-bound radioactivity was assessed by liquid scintillation count-
ing of the supernatant. The calculations were performed by software
specially designed to correct for the contribution of mass and radioac-
tivity of the recovery tracer in the RIA. Increasing cortisol levels up to
5 mol/liter revealed an overall contribution of cortisol in themeasured
21DF of less than 0.1%. Additions to serum of 21DF up to 35 nmol/liter
were fully recovered (102  1.8%). The detection limit was 0.16 nmol/
liter, when using a sample volume of 0.5 ml. Between-run CV was 7.8%
at a level of 10.6 nmol/liter. In 32 healthy volunteers (16male, 16 female),
values up to 1.8 nmol/liter were found. In three of these healthy indi-
viduals, 21DF levels were below the detection limit of the assay. ACTH
was measured by a two-step immunoradiometric assay (Dynotest
BRAHMS, Berlin, Germany) based on two monoclonal antibodies di-
rected against different antigenic determinants on the ACTH 1–39 mol-
ecule. Plasma renin was measured by immunoradiometric assay pro-
vided by CIS Bio International (Gif-sur-Yvette, France). Within- and
between-run CVs were 7.4 and 7.2% at 6.8 mU/liter, 6.2 and 2.6% at 37.4
mU/liter, and 1.3 and 4.7% at 216 8 mU/liter. Reference values are 7–75
mU/liter.
Molecular analysis
RNA extraction. Tissues stored at 80 C were pulverized using a mi-
crodismembrator (Braun, Melsungen, Germany) and kept in liquid ni-
trogen until RNA isolation. Total RNA was isolated from 20 mg tissue
powder using the RNeasy mini kit (QIAGEN, Hilden, Germany) with
on-column DNase-I treatment. Quality of the RNA was checked by
examining rRNA bands after agarose gel electrophoresis and by am-
plifying three housekeeping genes as a control (see below) (21). RNA
concentrations were determined from the spectrophotometric absorp-
tion at 260 nm using the Genequant (Amersham, Eindhoven, The
Netherlands).
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RT-PCR. Purified total RNA (1.0 g) was denatured for 10 min at 70 C
and immediately cooled on ice. RT was performed using the Reverse
Transcription System (Promega Benelux B.V., Leiden, The Netherlands)
according to the manufacturer’s protocol. After annealing of random
hexamers for 10 min at 20 C, cDNA synthesis was performed for 60 min
at 42 C followed by an enzyme inactivation step for 5 min at 95 C.
Quantitative PCRs forCYP11B1, CYP11B2,ACTH receptor, AII receptor,
and PBGD were performed using Sybr Green Master Mix (PE Applied
Biosystems, Nieuwerkerk a/d lJssel, The Netherlands) in a volume of 25
l. The primers used were CYPIIB1 forward, ggc aga ggc aga gat gct g;
CYPIIB1 reverse, tct tgg gtt agt gtc tcc acc tg; CYPIIB2 forward, ggc aga
ggc aga gat gct g; CYPIIB2 reverse, ctt gag tta gtg tct cca cca gga; ACTH
receptor forward, cga tcc cac acc agg aag at; ACTH receptor reverse, tca
gtg tga tgg ccc ctt tc; AII receptor forward, cct cgc tgt ggc tga ttt act c;
AII receptor reverse, ctt tgc aca tca cag gtc caa; PBGD forward, cat tgc
tgg taa cgg caa tg; and PBGD reverse, gta cga ggc ttt caa tgt tg.
Assays for HPRT and -actin were performed using predeveloped
assay reagents (PE Applied Biosystems) in Universal TaqMan Mix (PE
Applied Biosystems). Comparison of the potential normalizing genes
PBGD, HPRT, and -actin showed that -actin was the most consistent
within and between tissues. Therefore, all values are shown as relative
numbers of molecule gene of interest over molecules of -actin. Because
no absolute calibrator was used, all values are in arbitrary units. Am-
plifications, with denaturation at 95 C for 10 min, 40 cycles of 15 sec at
95 C (melting), and 60 sec at 60 C (annealing and elongation), were
performed on anABI Prism 7700 sequence detection system (PEApplied
Biosystems).
Statistical analysis
Data are expressed asmean sd. To compare different blood samples
within patients, paired t test was used to determine statistical signifi-
cance. Intergroup differences were tested using nonparametric tests and
Spearman rank correlation for correlation between parameters. A P
value  0.05 was considered significant (two-sided). None of the pa-
rameters investigated showed a significant difference in the mRNA
levels of tumors derived from the left and right testis of an individual
patient. Therefore, for statistical analyses, the mean value of the mea-
sured parameters of an individual patient was used.
Results
Histopathology
The mean weight of the tumors enucleated from the first
testes was 10.1  11.2 g (mean  sd; range 0.5–27.4 g) and
from the second testes 8.1  7.3 g (range 1.3–18.9 g) (Table
3). Macroscopically, all tumors were firm and multilobular
with a yellow to tan color on the cut surface and narrow
bands of fibrous tissue. Microscopically, the tumors were
sharply demarcated but unencapsulated and consisted of
sheets or confluent cords of large polygonal cells with abun-
dant eosinophilic cytoplasm, separated by dense fibrous tis-
sue strands. Reinke crystals were absent.
Spermatic vein sampling
The results of the spermatic vein samplings are listed in
Table 4. In all patients, variable levels of 21DF, 17OHP, and
A were measured. The mean 21DF concentration was 57.5
49.4 nmol/liter (mean sd; range 8.5–150 nmol/liter) in the
first cannulated spermatic vein and 34.1  33.1 nmol/liter
(range 1.5–87 nmol/liter) in the second cannulated spermatic
vein. Although the 21DF concentrations in the second sper-
TABLE 2. Serum levels of FSH, LH, testosterone, inhibin B, 17OHP, A, ACTH, and renin measured 3 d before testis-sparing surgery at
0900 h, before taking the morning dose of glucocorticoid in eight male CAH patients with bilateral testicular adrenal rest tumors
Patient
no.
FSH
(U/liter)
LH
(U/liter)
Testosterone
(nmol/liter)
Inhibin B
(ng/liter)
Estrone
(pmol/liter)
17OHP
(nmol/liter)
A
(nmol/liter)
ACTH
(pmol/liter)
Renin
(mU/liter)
1 0.2 0.2 37.0 nd 2700 720 100 156.0 1012.0
2 0.6 0.2 14.0 76 1100 480 86 180.0 46.0
3 8.6 5.2 17.0 65 140 26 1.5 9.1 39.0
4 15.9 2.9 13.0 47 650 367 14 42.2 119.0
5 0.2 0.2 9.8 80 1400 865 50 270.0 94
6 55.2 44.9 7.1 10 210 5.1 0.9 33.0 103
7 39.3 12.3 18.0 9 200 4.3 1.2 0.5  0.3
8 6.3 5.6 20.0 5 230 10 2.2 5.8 24
Normal values of our laboratory are as follows: FSH, 1.5–11 U/liter; LH, 1.4–8.5 U/liter; testosterone, 11–45 nmol/liter; inhibin B, 150–400
ng/liter; estrone, 65–220 pmol/liter; 17OHP, 2.0–10.8 nmol/liter; A, 1.4–9.7 nmol/liter; ACTH, 2.2–13.2 pmol/liter; renin, 5–75 mU/liter.
TABLE 3. Tumor weight and concentrations of 21DF, 17OHP, and A measured in spermatic veins and peripheral blood in seven of eight
CAH patients with bilateral testicular adrenal rest tumors
Patient no.
Tumor weight (g) 21 DF (nmol/liter) 17 OHP (nmol/liter) A (nmol/liter)
First Second P I II Ratio I/P P I II Ratio I/P P I II Ratio I/P
1 ND ND ND ND ND ND ND ND ND ND ND ND ND ND
2 13 11 5.1 52 59 10.2 16 140 130 8.75 4.4 21 9.1 4.8
3 4.3 5.5 1.4 65 3.6 46.4 3 170 77 56.6 0.3 20 6 62.5
4 27.4 18.9 8.0 150 87 18.8 6 260 160 43.3 0.8 20 5.1 26.3
5 0.9 1.6 22.0 74 27 3.4 46 190 78 4.1 7.2 19 5.2 2.6
6 22.9 16.2 0.3 53 54 160.6 0.5 320 450 640 0.4 65 59 185.7
7 0.5 1.3 0.3 ND 1.5 ND 2.2 ND 140 ND 0.5 ND 11 ND
8 1.5 1.9 0.3 8.5 6.7 25.8 4 170 280 42.5 0.6 36 80 65.5
Mean 10.1 8.1 (7.3) 5.4a 57.5 34.1 37.8 (56.3) 11.1b 208.0 187.0 132.0 (249) 2.0c 30.1 25.06 57.0
(SD) (11.2) (8.0) (49.4) (33.1) (16.2) (67.9) (134) (2.7) (18.2) (31.0) (68.2)
First and second indicate first and second enucleated tumors. P indicates peripheral blood sample, I indicates first spermatic vein sample,
and II indicates second spermatic vein sample. The peripheral blood sample was taken simultaneously with the first spermatic vein sampling
(I). In patient 1, only tumor size was measured, and spermatic vein sampling was not performed. In patient 7, spermatic veins on the right
side were atrophic and could not be cannulated. ND, Not determined.
a–c P value gives the Spearman’s correlation between I and P of each parameter: a P  0.02; b P  0.001, c P  0.01.
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matic vein were lower than in the first cannulated vein,
probably because of ongoing suppression of ACTH due to
DXM given just before surgery, the difference between the
two measurements was not significant (P  0.09). The mean
21DF concentration in peripheral blood was 5.4 8.0 nmol/
liter (range 0.3–22 nmol/liter) and was significantly lower
than the concentration in simultaneously taken first sper-
matic vein blood (P  0.02). The mean ratio ( sd) of 21DF
concentration in blood of the first cannulated spermatic vein
and the simultaneously collected peripheral blood was
37.8  56.3 (P  0.02). The mean 17OHP and A levels in the
first cannulated spermatic veinwere also significantly higher
compared with those in simultaneously taken peripheral
blood (P  0.001 and P  0.01, respectively). There were no
significant correlations between the concentrations of the
steroids measured in the spermatic veins and tumor weight.
Expression analysis
CYP11B1 and CYP11B2 mRNAs were clearly detectable in
all tumor samples. The mean CYP11B1 level was 4.1  3.1
(mean sd; range 0.7–8.5) and the mean CYP11B2 level was
3.4  2.6 (range 0.4–7.5) with a strong correlation between
these two measurements (r  0.95; P  0.01). mRNA of
ACTH receptors (0.2 0.2; mean sd; range 0–0.6) and AII
receptors (0.19  0.032; range 0.00032–0.112) were also
present in all tumor samples. Values are shown as relative
numbers of molecule gene of interest over molecule of
-actin.
The correlations between mRNA expression of ACTH re-
ceptors, AII receptors, CYP11B1, and CYP11B2 and the ste-
roid hormones 21DF, 17OHP, and A measured in the sper-
matic veins and peripheral blood are listed in Table 4. There
was a strong positive correlation between tumor ACTH re-
ceptor levels and 21DF (r  0.85; P  0.015), 17OHP (r  1;
P 0.01), andA concentration (r 0.89; P 0.007)measured
in peripheral blood, suggesting a strong influence of hor-
monal control on ACTH receptor levels in the tumors. No
other significant correlations were found.
Discussion
Testicular adrenal rest tumors inmale CAHpatients are of
great interest because of their high prevalence and severe
consequences for gonadal function. Although several studies
describe functional characteristics of these tumors, mainly in
case reports, our study is the first providing functional fea-
tures of a series of 16 testicular tumors from eight adult CAH
patients.
Histologically, all tumors showed a similar appearance
with microscopically specific features of steroid-producing
cells in agreement with previous studies (4–6). In all but one
patient, in whom cannulation of the spermatic vein was not
completely successful, the concentration of the adrenal-spe-
cific steroid 21DF in the spermatic veins was significantly
higher than the concentration in peripheral blood samples,
which suggests local production of these steroids in the tes-
tes. Additionally, our study clearly shows the presence at the
mRNA level of the adrenal-specific enzymes CYP11B1 and
CYP11B2 and of ACTH and AII receptors in all testicular
tumors, strongly suggesting that the tumors consists of ad-
renal-like tissue.
Ectopic adrenocortical tissue is found in up to 50% of
neonates and usually atrophies during childhood (22). Most
ectopic adrenal tissue is found in the vicinity of the adrenals
around the celiac axis and in the testes (surgery or autopsy
findings). In the embryological period, steroidogenic cells
destined to become adrenal and gonadal cells derive from
neighboring areas of the coelomic epithelium and are mor-
phologically identical. Separation of the cells takes place at
approximatelywk 8 of gestation, and further development of
the cells depends on the expression of specific transcription
factors (23, 24). During further development, adrenal cells
can migrate together with the descending testis. Adrenal
rests within the testis occur in 7.5–15% of neonates and nor-
mally regress in early infancy (25, 26). However, in CAH
patients, it is believed that these cells can persist and pro-
liferate with preservation of adrenal-like hormone-produc-
ing properties.
Functional adrenal zonation of testicular adrenal rests due
to zona-specific expression of enzymes involved in steroid
biosynthesis has never been described. It is known that in the
human adrenal gland CYP11B1 is expressed in high levels in
the zona fasciculata/reticularis where it catalyzes the 11-
hydroxylation of 11-deoxycortisol to cortisol (27). CYP11B2
is exclusively expressed in the zona glomerulosa where it is
responsible for the final step of the aldosterone synthesis
pathway (28, 29). The presence of CYP11B1 in the zona glo-
TABLE 4. Spearman rank correlation between mean of both tumors in individual patients of ACTH receptor, AII receptor, and CYP11B1
and CYP11B2 mRNA levels measured in removed tumor tissue by real-time PCR and 21DF, 17OHP, and A measured in spermatic veins
and simultaneously taken peripheral blood samples in eight CAH patients with bilateral adrenal rest tumors treated with testis-sparing
surgery
Spermatic vein samples Peripheral blood samples mRNA levels (Q-PCR)
21DF 17OHP A 21DF 17OHP A AII CYP11B1 CYP11B2
mRNA levels
(Q-PCR)
ACTH rec 0.43 (0.34) 0.35 (0.50) 0.67 (0.15) 0.85 (0.015a) 1 (0.01b) 0.89 (0.007b) 0.38 (0.35) 0.17 (0.69) 0.17 (0.69)
AII rec 2.86 (0.54) 0.09 (0.87) 0.41 (0.43) 0 (1.0) 0.14 (0.76) 0.43 (0.34) 0.26 (0.53) 0.38 (0.35)
CYP11B1 0.21 (0.65) 0.41 (0.43) 0.32 (0.54) 0.37 (0.41) 0.32 (0.48) 0.14 (0.76) 0.95 (0.01b)
CYP11B2 0.43 (0.34) 0.23 (0.66) 0.64 (0.17) 0.52 (0.23) 0.32 (0.48) 0.07 (0.88)
Numbers express correlation coefficients, with two-sided P value in parentheses. Values are shown as relative numbers of molecule gene of
interest over molecule of -actin. ACTH rec, Mean ACTH receptor mRNA level measured in tumor tissue; AII rec, mean AII receptor mRNA
level measured in tumor tissue; CYP11B1 and CYP11B2, mean enzyme mRNA level of CYP11B1 and CYP11B2 measured in tumor tissue;
Q-PCR, real-time PCR.
a Correlation is significant at the 0.05 level (two-sided).
b Correlation is significant at the 0.01 level (two-sided).
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merulosa is controversial (30). So, the presence of CYP11B1
and CYP11B2 in tumor tissue of all patients in our study
group suggests that the tumors may have functional features
of both adrenal zona fasciculata and glomerulosa cells. Fur-
thermore, our study shows that these tumors are very het-
erogeneous with respect to steroid hormone production and
that at least at themRNA level, they contain varying amounts
of steroid-producing enzymes and ACTH and AII receptors.
The factors that are responsible for growth of adrenal rest
tissue in CAH patients are not fully understood. Testicular
adrenal rest tumors are often found in patients with poor
hormonal control and high ACTH levels, suggesting that
ACTH is a dominant factor in tumor growth (2, 3). In the
complete absence of 21-hydroxylase activity, plasma levels of
ACTH are extremely high from early prenatal life, probably
explaining the higher incidence of testicular tumors in SW
CAH patients compared with SV CAH patients (12). How-
ever, in several studies, no correlation was found between
ACTH levels and tumor growth (2, 3, 12). Therefore, most
probably other factors contribute to tumor growth.
In our study, we foundmRNA expression of AII receptors
in all testicular tumors. These findings are in agreement with
the study of Clark et al. (13) who described AII receptor
concentrations in a testicular adrenal rest tumor of a CAH
patient similar to that in normal adrenal tissue. It is known
that AII has a strong trophic effect on the adrenal gland,
especially on the zona glomerulosa (31–34). These trophic
effects were studied in detail by Chatelain et al. (31) in adult
rats showing that water deprivation resulted in high AII
levels without affecting ACTH levels and in increase of ad-
renal zona glomerulosa weight. Inhibition of AII production
by angiotensin-converting enzyme inhibitors significantly
decreased adrenal weight, suggesting that AII is an impor-
tant factor in stimulation of adrenal growth. AII markedly
increases levels of both CYP11B1 and CYP11B2 mRNA,
whereas ACTH causes an acute increase of CYP11B1 mRNA
levels without an effect on CYP11B2 transcription (31). We
hypothesize that tumor growth in CAH patients may be
stimulated not only by elevated ACTH concentrations but
also by elevated AII levels, which are present in SW patients
with poor hormonal control. Interestingly, in late-onset CAH
patients, without clearly elevated ACTH or AII levels, tes-
ticular tumors are never described. Additional studies are
necessary to study the effect of AII on growth of testicular
tumors in CAH patients.
In summary, testicular adrenal rest tumors in CAH pa-
tients produce adrenal-specific steroids and contain adrenal-
specific enzymes confirming the adrenal-like properties of
the tumors. Based on the presence of AII receptors, we hy-
pothesize that AIImay be an additional factor responsible for
tumor growth in patients with poor hormonal control. Ad-
ditional investigationswill be necessary to determine the role
of AII in testicular tumor growth.
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